“…Generally, GSTM1 can detoxify reactive metabolites of benzo(a)pyrene and other PAHs (Smart and Daly, 2000;Chen et al, 2006;Giri et al, 2012). Here, we found that the frequency of variants in the AhR Lys 554 and CYP1A1 val variant genotype and GSTM1 null genotype showed slight higher in exposed group (63.7%, 62.8%, 58.4%, respectively) than in control subjects (59.8%, 61.0%, 57.3%, respectively) on urinary 1-OHP excretion, though did not show significant differences.…”